期刊文献+

氢氧化铝佐剂对铜绿假单胞菌11型O-特异性多糖与破伤风类毒素结合物免疫原性和免疫保护性的影响 被引量:1

Effect of Al(OH)_3 adjuvant on immunogenicity and immune protection of a conjugate composed of Pseudomonas aeruginosa(IATS 11) O-specific polysaccharide bounds with tetanus toxoid
下载PDF
导出
摘要 目的评价氢氧化铝[Al(OH)3]佐剂对铜绿假单胞菌11型O-特异性多糖与破伤风类毒素结合物免疫原性和免疫保护性的影响。方法用热酚水法提取铜绿假单胞菌11型(IATS 11)菌株的脂多糖(LPS),去除类脂A并纯化O-特异性多糖(O-SP),用1-氰基-4-二甲胺基吡啶四氟硼酸盐(CDAP)活化O-SP,己二酸二肼(ADH)作连接臂,在乙基二甲氨基丙基碳二亚胺盐酸盐(EDAC)作用下,与破伤风类毒素(TT)结合制备出O-SP-TT结合物,并对该结合物进行添加Al(OH)3佐剂和不添加该佐剂的小鼠免疫原性试验和免疫保护性试验。结果加有Al(OH)3佐剂的结合物在小鼠免疫原性试验中,产生了高效价的IgG抗体,与不添加该佐剂试验组相比,差异具有统计学意义(P<0.05);免疫保护性试验表明,添加Al(OH)3佐剂结合物免疫小鼠对5~10 LD50活菌的腹腔攻击具有良好的保护作用。结论 Al(OH)3佐剂对本结合物有优良的免疫增强作用,添加该佐剂的结合物可望有效防止IATS 11型铜绿假单胞菌感染。 Objective To investigate effect of Al(OH)3 adjuvant on immunogenicity and immune protection of a conjugate composed of Pseudomonas aeruginosa(IATS 11)O-specific polysaccharide bounds with tetanus toxoid.Method Lipopolysaccharide(LPS) from Pseudomonas aeruginosa bacteria(IATS 11) was isolated via hot phenol extraction and then hydrolyzed to obtain O-specific polysaccharide(O-SP).O-SP was activated with CDAP,using adipic acid dihydrazide as a linker.Activated O-SP was conjugated to tetanus toxoid via EDAC mediated condensation reaction.Immunogenicity of the conjugate with Al(OH)3 adjuvant or without the adjuvant and its immune protection were evaluated in mice.The challenge test was conducted in mice immunized with the conjugate.Results Significantly high IgG anti-IATS 11 O-SP levels were induced in the mice immunized with the conjugates with Al(OH)3 adjuvant comparing with that of immunized with the conjugates without the adjuvant(P0.05).The potency study showed that more than 80% of the mice immunized with the conjugate with the adjuvant survived when challenged with bacteria of 5—10 LD50.Conclusion Al(OH)3 adjuvant showed that great immunopotentiation and the conjugate with the adjuvant is expected to effectively against IATS 11 Pseudomonas aeruginosa.
出处 《微生物学免疫学进展》 2013年第4期12-18,共7页 Progress In Microbiology and Immunology
关键词 铜绿假单胞菌 O-特异性多糖 结合物 Al(OH)3佐剂 免疫原性 免疫保护性 Pseudomonas aeruginosa O-specific polysaccharide(O-SP) Conjugate Al(OH) 3 adjuvant Immunogenicity Vaccine potency
  • 相关文献

参考文献10

  • 1谢茂超,陈明拓,姜晓,杨硕,王学林,葛永红.铜绿假单胞菌6型O-特异性多糖与破伤风类毒素结合物免疫原性研究[J].微生物学免疫学进展,2012,40(4):10-14. 被引量:1
  • 2谢茂超,陈明拓,姜晓,杨硕,吴鸿舟,王学林,赵高梅,葛永红.铜绿假单胞菌3型O-特异性多糖-破伤风类毒素结合疫苗的制备及其免疫特性分析[J].中国生物制品学杂志,2012,25(12):1565-1568. 被引量:3
  • 3Kossaczka Z, Shiloaeh J, Ohnson V, et al. Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diph- theria toxin mutant in mice[J]. Infect lmmun, 2000, 68 ( 9 ) : 5037 -5043.
  • 4Tam VH, Chang KT, Abdelraouf K, et al. Prevalence, resistance mechanisms, and susceptibility of muhidrug-resistant bloodstream isolates of Pseudonwnas aeruginosa[J]. Antimicrob Agents Che- mother, 2010, 54(3) :1160-1164.
  • 5Kamei A, Wu WH, Traficante DC, et al. Collaboration between maerophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutrope- nia[J]. J Infect Dis, 2013, 207(1) :39-49.
  • 6Akhabue E, Synnestvedt M, Weiner MG, et al. Cefepime-resist- ant Pseudomonas aeruginosa [ J ]. EID J, 2011,17 ( 6 ) : 1037- 1043.
  • 7Doring G,Pier GB. Vaccines and immunotherapy against Pseudo- monas aeruginosa [ J ]. Vaccine, 2008, 26 ( 8 ) : 1011 - 1024.
  • 8de Bentzmann S, Pl~siat P. The Pseudomonas aer~ginosa oppor- tunistic pathogen and human infections [J]. Environ Microbiol, 2011,13 (7) :1655-1665.
  • 9Hota S, Hirji Z, Stockton K, et al. Outbreak of multidrug-resist- ant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design [ J]. Infect Control Hosp Epidemiol, 2009, 30( 1 ) :25-29.
  • 10Knirel YA, Vinogradov EV, Kocharova NA, et al. The structure of O-specific polysaccharides and serological classification of Pseudomonas aeruginosa [ J ]. Acta Micmbiologica Hungarica, 1988, 35(1) :3-24.

二级参考文献17

  • 1Akhabue E, Synnestvedt M, Weiner M G, et al. Cefepime-resist- ant Pseudomonas aerugi-nosa [ J]. EID Journal, 2011,17 ( 6 ) :1037-1043.
  • 2Mesaros N, Nordmann P, Plesiat P, et al. Pseudomonas aerugi- nosa : resistance and therapeutic options at the turn of the new mil- lenninm[J]. Clin Microbiol Infect, 2007, 13:560-578.
  • 3Doring G, Pier G B. Vaccines and immunotherapy against Pseudo- rnonas aeruginosa [ J]. Vaccine, 2008, 26 : 1011-1024.
  • 4de Bentzmann S, P16siat P. The Pseudomonas aeruginosa oppor- tunistic pathogen and human infections [ J ]. Environ Microbiol, 2011,13(7) :1655-1665.
  • 5Gales A C, Jones R N, Tumidge J, et al. Characterization of Pseudomonas aeruginosa isolates [ J ]. Clin Infect Dis, 2001,32 ($2) : 146-155.
  • 6Kossaczka Z, Shiloach J, Ohnson V, et al. Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diph- theria toxin mutant in mice [ J ]. Infect Immun, 2000, 68 (9) : 50375 -043.
  • 7Lees A, Nelson B L, Mond J J. Activation of soluble polysaccha- rides with 1-cyano-4-dimethyl amino pyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immuno- logical reagents[J]. Vaccine, 1996, 14(3) :190-198.
  • 8Hota S, Hirji Z, Stockton K, et al. Outbreak ofmuhidrug-resistant Pseudomonas aeruginosa colonization and infection secondary to imperfect intensive care unit room design[ J]. Infect Control Hosp Epidemiol, 2009, 30 ( 1 ) :25-29.
  • 9Knirel Y A, Vinogradov E V, Kocharova N A, et al. The struc- ture of O-specific polysacchari-des and serological classification of Pseudomonas aeruginosa [ J ]. Acta Microbiologica Hungarica, 1988, 35(1) :3-24.
  • 10Rodrfguez-Rojas A,Oliver A, B16zquez J. Intrinsic and environ- mental mutagensis drive diversification and persistence of Pseu- domonas aeruginosa in chronic lung infections [J]. J Infect Dis, 2012, 205 (1): 121-127.

共引文献2

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部